Dr. Matthew Harmelink, MD

Claim this profile

Children's Wisconsin

Studies Muscular Dystrophy

Studies Duchenne Muscular Dystrophy

4 reported clinical trials

5 drugs studied

Area of expertise

1Muscular Dystrophy

Matthew Harmelink, MD has run 3 trials for Muscular Dystrophy. Some of their research focus areas include:

DMD negative

DMD positive

2Duchenne Muscular Dystrophy

Matthew Harmelink, MD has run 3 trials for Duchenne Muscular Dystrophy. Some of their research focus areas include:

DMD negative

DMD positive

Affiliated Hospitals

Children's Wisconsin

Children's Hospital Of Wisconsin

More about Matthew Harmelink, MD

Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Matthew Harmelink, MD has experience with

Placebo
SRP-9001 (Delandistrogene Moxeparvovec)
Prospective Observational Registry
Zolgensma
CAP-1002

Breakdown of trials Matthew Harmelink, MD has run

Muscular Dystrophy

Duchenne Muscular Dystrophy

Muscle Atrophy

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Spinal Muscular Atrophy

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Atrophy

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

What does Matthew Harmelink, MD specialize in?

Matthew Harmelink, MD focuses on Muscular Dystrophy and Duchenne Muscular Dystrophy. In particular, much of their work with Muscular Dystrophy has involved DMD negative patients, or patients who are DMD positive.

Is Matthew Harmelink, MD currently recruiting for clinical trials?

No, Matthew Harmelink, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.

Are there any treatments that Matthew Harmelink, MD has studied deeply?

Yes, Matthew Harmelink, MD has studied treatments such as Placebo, SRP-9001 (Delandistrogene Moxeparvovec), Prospective observational registry.

What is the best way to schedule an appointment with Matthew Harmelink, MD?

Apply for one of the trials that Matthew Harmelink, MD is conducting.

What is the office address of Matthew Harmelink, MD?

The office of Matthew Harmelink, MD is located at: Children's Wisconsin, Milwaukee, Wisconsin 53226 United States. This is the address for their practice at the Children's Wisconsin.

Is there any support for travel costs?

The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

1045 Sansome St, Suite 321, San Francisco, CA

hello@withpower.com (415) 900-4227

Directories

Locations

Psychology Related

Treatments

Cities

···

Dr. Matthew Harmelink, MD

Children's Wisconsin

Area of expertise

Affiliated Hospitals

More about Matthew Harmelink, MD

Other Doctors you might be interested in

Frequently asked questions

Personalize Your Experience

Save Your Preferences

Understand How the Site Is Used